Fish oil therapy in recurrent IgA nephropathy.
- Published in:
- 2003
- By:
- Publication type:
- Case Study
Works matching IS 00034819 AND DT 2003 AND VI 138 AND IP 12
Results: 32
1
2
A road less traveled.
- Published in:
- 2003
- Publication type:
- journal article
3
Summaries for patients. Excluding pulmonary embolism safely.
- Published in:
- 2003
- Publication type:
- journal article
4
Summaries for patients. Cost-effectiveness of pneumococcal vaccine for people 50 through 64 years of age.
- Published in:
- 2003
- Publication type:
- journal article
5
A need to update and revise the pneumococcal vaccine recommendations for adults.
- Published in:
- 2003
- By:
- Publication type:
- commentary
6
The In-Training Examination in Internal Medicine.
- Published in:
- 2003
- By:
- Publication type:
- commentary
7
Summaries for patients. Inhaled steroids for chronic obstructive lung disease.
- Published in:
- 2003
- Publication type:
- journal article
8
Summaries for patients. A comparison of three insulin regimens (morning glargine, bedtime glargine, or bedtime neutral protamine Hagedorn) in addition to a pill for treating type 2 diabetes.
- Published in:
- 2003
- Publication type:
- journal article
9
Inhaled corticosteroids and chronic obstructive pulmonary disease: are we barking up the wrong tracheobronchial tree?
- Published in:
- 2003
- By:
- Publication type:
- commentary
10
Statin-associated myopathy with normal creatine kinase levels.
- Published in:
- 2003
- By:
- Publication type:
- commentary
11
The relative safety of ephedra compared with other herbal products.
- Published in:
- 2003
- By:
- Publication type:
- commentary
12
Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis.
- Published in:
- 2003
- By:
- Publication type:
- journal article
13
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
14
Physicians Contribute Professional Expertise Worldwide.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 1013, doi. 10.7326/0003-4819-138-12-200306170-00032
- Publication type:
- Article
15
Letters.
- Published in:
- 2003
- Publication type:
- Letter
16
A Road Less Traveled.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 1004
- By:
- Publication type:
- Article
17
The sustenance of teaching.
- Published in:
- 2003
- By:
- Publication type:
- journal article
18
Inhaled Corticosteroids and Chronic Obstructive Pulmonary Disease: Are We Barking Up the Wrong Tracheobronchial Tree?
- Published in:
- 2003
- By:
- Publication type:
- Editorial
19
A Need To Update and Revise the Pneumococcal Vaccine Recommendations for Adults.
- Published in:
- 2003
- By:
- Publication type:
- Editorial
20
Patient safety and the reliability of health care systems.
- Published in:
- 2003
- By:
- Publication type:
- commentary
21
Improving patient care.
- Published in:
- 2003
- By:
- Publication type:
- commentary
22
Zen and the Art of Physician Autonomy Maintenance.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 992, doi. 10.7326/0003-4819-138-12-200306170-00011
- By:
- Publication type:
- Article
23
A Physiologic Approach to Diagnosis of the Cushing Syndrome.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 980, doi. 10.7326/0003-4819-138-12-200306170-00010
- By:
- Publication type:
- Article
24
Inhaled Steroids for Chronic Obstructive Lung Disease.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. I46, doi. 10.7326/0003-4819-138-12-200306170-00004
- Publication type:
- Article
25
Long-Term Effects of Inhaled Corticosteroids on FEV[sub1] in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 969, doi. 10.7326/0003-4819-138-12-200306170-00008
- By:
- Publication type:
- Article
26
Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 960, doi. 10.7326/0003-4819-138-12-200306170-00007
- By:
- Publication type:
- Article
27
Excluding Pulmonary Embolism Safely.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. I18, doi. 10.7326/0003-4819-138-12-200306170-00001
- Publication type:
- Article
28
Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review.
- Published in:
- 2003
- By:
- Publication type:
- journal article
29
Error, Blame, and the Law in Health Care--An Antipodean Perspective.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 974, doi. 10.7326/0003-4819-138-12-200306170-00009
- By:
- Publication type:
- Article
30
Cost-Effectiveness of Pneumococcal Vaccine for People 50 through 64 Years of Age.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. I42, doi. 10.7326/0003-4819-138-12-200306170-00003
- Publication type:
- Article
31
A Comparison of Three Insulin Regimens (Morning Glargine, Bedtime Glargine, or Bedtime Neutral Protamine Hagedorn) in Addition to a Pill for Treating Type 2 Diabetes.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. I33, doi. 10.7326/0003-4819-138-12-200306170-00002
- Publication type:
- Article
32
Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 Diabetes.
- Published in:
- Annals of Internal Medicine, 2003, v. 138, n. 12, p. 952
- By:
- Publication type:
- Article